Aug 27 (Reuters) - Drug companies Jazz (JAZZ.O), opens new tab and Hikma (HIK.L), opens new tab must face claims that they schemed to delay a generic version of Jazz’s blockbuster narcolepsy ...

The acquisition includes a commercial portfolio and pipeline of differentiated products, a manufacturing facility in ...

Hikma is offering clindamycin in 5% dextrose injection, in 300mg/50ml, 600mg/50ml and 900mg/50ml doses. The product is available in a vial. Clindamycin in 5% dextrose injection is indicated for ...

and Hikma Pharmaceuticals Plc (OTC:HKMPF) (OTC:HKMPY) are set to face allegations that they conspired to delay the release of ...

Unlike opioids, which can be countered with naloxone, also known as Narcan, medetomidine doesn't respond to the life-saving drug, making it even more dangerous when mixed with other substances.Aug ...

That has meant turning from tracking infections to tracking illicit and high-risk drug use. Monitoring wastewater for viruses works because infected people excrete tiny bits of viral matter ...

A psychotropic describes any drug that affects behavior, mood, thoughts, or perception. This can include medications for anxiety and depression as well as antipsychotics, among others ...

Members of my lab are interested in how hormones act in the brain to influence response to drugs of abuse. This student was engaged in primarily archival research on this topic. During her time ...

AMSTERDAM—Organized crime used to be considered a remote threat in much of Western Europe, but ruthless violence by criminal gangs is now rattling the peace in some of the world’s safest ...

Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today welcomed Dr. Rahul Gupta, Director of the White House Office of National Drug Control Policy (ONDCP), to its ...

Novel chemical tool aims to streamline drug-making process Results seen as possible breakthrough in organic chemistry Date: August 30, 2024 Source: Ohio State University Summary: The invention of ...

Hikma’s generic version of Xyrem only reached the market last year, following a 2017 settlement that the plaintiffs allege was an unlawful “reverse payment agreement” designed to delay ...